Sickle cell treatment enters Phase 3 clinical trial
Friday, July 23, 2010 - 11:21
in Health & Medicine
An experimental treatment for sickle cell disease developed at the Los Angeles Biomedical Research Institute (LA BioMed) has entered Phase 3 clinical trials, David I. Meyer, PhD, LA BioMed president and CEO announced today.